Medicine

J. Hammarsten, B. Högstedt, N. Holthuis, D. Mellström

1998.3.1PROSTATE CANCER AND PROSTATIC DISEASES

DOI: 10.1038/sj.pcan.4500221

tlooto Summary

It is concluded that NIDDM, treated hypertension, obesity, low HDL-cholesterol levels and high insulin levels constitute risk factors for the development of BPH and that BPH patients may share the same metabolic abnormalities of a defective insulin-mediated glucose uptake and secondary hyperinsulinemia as patients with the metabolic syndrome.

Abstract

Abstract is not available.

Citation format

HAMMARSTEN, J., et al. Components of the metabolic syndrome—risk factors for the development of benign prostatic hyperplasia. PROSTATE CANCER AND PROSTATIC DISEASES, 1998, 1: 157–162.